HPSE and cancer: These include benzoxazoles [69], benzoimidazoles [70], HS-configured pseudodisaccharides [58], and heparanase-neutralizing antibodies [71], all of which showed specific anti-heparanase-1 and anti-cancer activity in vitro in nanomolar concentrations.